These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 34713419)

  • 1. Preadmission usage of metformin and mortality in COVID-19 patients including the post-discharge period.
    Saygili ES; Karakiliç E; Mert E; Şener A; Mirci A
    Ir J Med Sci; 2022 Apr; 191(2):569-575. PubMed ID: 34713419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Long-term Effects of Metformin on Patients With Type 2 Diabetic Kidney Disease.
    Kwon S; Kim YC; Park JY; Lee J; An JN; Kim CT; Oh S; Park S; Kim DK; Oh YK; Kim YS; Lim CS; Lee JP
    Diabetes Care; 2020 May; 43(5):948-955. PubMed ID: 32132005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin is associated with favorable outcomes in patients with COVID-19 and type 2 diabetes mellitus.
    Ma Z; Patel N; Vemparala P; Krishnamurthy M
    Sci Rep; 2022 Apr; 12(1):5553. PubMed ID: 35365744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin use is associated with a decrease in the risk of hospitalization and mortality in COVID-19 patients with diabetes: A population-based study in Lombardy.
    Ojeda-Fernández L; Foresta A; Macaluso G; Colacioppo P; Tettamanti M; Zambon A; Genovese S; Fortino I; Leoni O; Roncaglioni MC; Baviera M
    Diabetes Obes Metab; 2022 May; 24(5):891-898. PubMed ID: 35014746
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between Preoperative Metformin Exposure and Postoperative Outcomes in Adults With Type 2 Diabetes.
    Reitz KM; Marroquin OC; Zenati MS; Kennedy J; Korytkowski M; Tzeng E; Koscum S; Newhouse D; Garcia RM; Vates J; Billiar TR; Zuckerbraun BS; Simmons RL; Shapiro S; Seymour CW; Angus DC; Rosengart MR; Neal MD
    JAMA Surg; 2020 Jun; 155(6):e200416. PubMed ID: 32267474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of different treatments for type 2 diabetes mellitus on mortality of coronavirus disease from 2019 to 2021 in China: a multi-institutional retrospective study.
    Xu K; He W; Yu B; Zhong K; Zhou D; Wang DW
    Mol Biomed; 2024 May; 5(1):18. PubMed ID: 38755442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is metformin use associated with low mortality in patients with type 2 diabetes mellitus hospitalized for COVID-19? a multivariable and propensity score-adjusted meta-analysis.
    Ma Z; Krishnamurthy M
    PLoS One; 2023; 18(2):e0282210. PubMed ID: 36821577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin use is associated with a reduced risk of mortality in patients with diabetes hospitalised for COVID-19.
    Lalau JD; Al-Salameh A; Hadjadj S; Goronflot T; Wiernsperger N; Pichelin M; Allix I; Amadou C; Bourron O; Duriez T; Gautier JF; Dutour A; Gonfroy C; Gouet D; Joubert M; Julier I; Larger E; Marchand L; Marre M; Meyer L; Olivier F; Prevost G; Quiniou P; Raffaitin-Cardin C; Roussel R; Saulnier PJ; Seret-Begue D; Thivolet C; Vatier C; Desailloud R; Wargny M; Gourdy P; Cariou B;
    Diabetes Metab; 2021 Sep; 47(5):101216. PubMed ID: 33309936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preadmission metformin use and mortality among intensive care patients with diabetes: a cohort study.
    Christiansen C; Johansen M; Christensen S; O'Brien JM; Tønnesen E; Sørensen H
    Crit Care; 2013 Sep; 17(5):R192. PubMed ID: 24018017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis.
    Bramante CT; Ingraham NE; Murray TA; Marmor S; Hovertsen S; Gronski J; McNeil C; Feng R; Guzman G; Abdelwahab N; King S; Tamariz L; Meehan T; Pendleton KM; Benson B; Vojta D; Tignanelli CJ
    Lancet Healthy Longev; 2021 Jan; 2(1):e34-e41. PubMed ID: 33521772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin use and mortality and length of stay among hospitalized patients with type 2 diabetes and COVID-19: A multiracial, multiethnic, urban observational study.
    Miao E; Zhang K; Liu J; Lin J; Yoo D; George CJ
    Front Endocrinol (Lausanne); 2022; 13():1002834. PubMed ID: 36440189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Metformin with Susceptibility to COVID-19 in People with Type 2 Diabetes.
    Wang J; Cooper JM; Gokhale K; Acosta-Mena D; Dhalla S; Byne N; Chandan JS; Anand A; Okoth K; Subramanian A; Bangash MN; Jackson T; Zemedikun D; Taverner T; Hanif W; Ghosh S; Narendran P; Toulis KA; Tahrani AA; Surenthirakumaran R; Adderley NJ; Haroon S; Khunti K; Sainsbury C; Thomas GN; Nirantharakumar K
    J Clin Endocrinol Metab; 2021 Apr; 106(5):1255-1268. PubMed ID: 33560344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin use and mortality in patients with advanced chronic kidney disease: national, retrospective, observational, cohort study.
    Hung SC; Chang YK; Liu JS; Kuo KL; Chen YH; Hsu CC; Tarng DC
    Lancet Diabetes Endocrinol; 2015 Aug; 3(8):605-14. PubMed ID: 26094107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin Use and Clinical Outcomes Among Patients With Diabetes Mellitus With or Without Heart Failure or Kidney Dysfunction: Observations From the SAVOR-TIMI 53 Trial.
    Bergmark BA; Bhatt DL; McGuire DK; Cahn A; Mosenzon O; Steg PG; Im K; Kanevsky E; Gurmu Y; Raz I; Braunwald E; Scirica BM;
    Circulation; 2019 Sep; 140(12):1004-1014. PubMed ID: 31362530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: A retrospective cohort study.
    Jiang N; Chen Z; Liu L; Yin X; Yang H; Tan X; Wang J; Li H; Tian M; Lu Z; Xiong N; Gong Y
    Diabetes Res Clin Pract; 2021 Mar; 173():108619. PubMed ID: 33310173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there an association between metformin use and clinical outcomes in diabetes patients with COVID-19?
    Do JY; Kim SW; Park JW; Cho KH; Kang SH
    Diabetes Metab; 2021 Jul; 47(4):101208. PubMed ID: 33160030
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of metformin, insulin on COVID-19 patients with pre-existed type 2 diabetes: A multicentral retrospective study.
    Cheng X; Xin S; Chen Y; Li L; Chen W; Li W; Zhou B; Li C; Gong Y; Li F; Duan P; Zhou X
    Life Sci; 2021 Jun; 275():119371. PubMed ID: 33745895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin versus sulphonylureas for new onset atrial fibrillation and stroke in type 2 diabetes mellitus: a population-based study.
    Zhou J; Zhang G; Chang C; Chou OHI; Lee S; Leung KSK; Wong WT; Liu T; Wai AKC; Cheng SH; Zhang Q; Tse G
    Acta Diabetol; 2022 May; 59(5):697-709. PubMed ID: 35112189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preadmission use of antidiabetic medications and mortality among patients with COVID-19 having type 2 diabetes: A meta-analysis.
    Nguyen NN; Ho DS; Nguyen HS; Ho DKN; Li HY; Lin CY; Chiu HY; Chen YC
    Metabolism; 2022 Jun; 131():155196. PubMed ID: 35367460
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin use before COVID-19 vaccination and the risks of COVID-19 incidence, medical utilization, and all-cause mortality in patients with type 2 diabetes mellitus.
    Yen FS; Wang SI; Lin SY; Wei JC
    Diabetes Res Clin Pract; 2023 Jun; 200():110692. PubMed ID: 37156428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.